Successfully controlling the incidence of multidrug-resistant Pseudomonas aeruginosa through antibiotic stewardship and infection control programmes at a Chinese university hospital
被引:3
|
作者:
Li, Qiu-Yan
论文数: 0引用数: 0
h-index: 0
机构:
Harbin Med Univ, Affiliated Hosp 4, Dept Geriatr, Harbin, Peoples R ChinaHarbin Med Univ, Affiliated Hosp 4, Dept Geriatr, Harbin, Peoples R China
Li, Qiu-Yan
[1
]
Liu, Bin
论文数: 0引用数: 0
h-index: 0
机构:
Harbin Med Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Harbin, Peoples R ChinaHarbin Med Univ, Affiliated Hosp 4, Dept Geriatr, Harbin, Peoples R China
Liu, Bin
[2
]
Liu, Lei
论文数: 0引用数: 0
h-index: 0
机构:
Harbin Med Univ, Affiliated Hosp 4, Dept Resp Med, Harbin, Peoples R ChinaHarbin Med Univ, Affiliated Hosp 4, Dept Geriatr, Harbin, Peoples R China
Liu, Lei
[3
]
机构:
[1] Harbin Med Univ, Affiliated Hosp 4, Dept Geriatr, Harbin, Peoples R China
[2] Harbin Med Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Harbin, Peoples R China
[3] Harbin Med Univ, Affiliated Hosp 4, Dept Resp Med, Harbin, Peoples R China
What is known and Objective The purpose of this study was to investigate the effect of imposing infection control programmes (ICPs) and antimicrobial stewardship (AMS) by monitoring the antimicrobial resistance of Pseudomonas aeruginosa. Methods Antimicrobial susceptibility testing was performed in accordance with the Clinical and Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing guidelines. ICPs and AMS were initiated at the Fourth Hospital from 2013 to 2018. Results and discussion A total of 2,886 P. aeruginosa isolates were assessed. The antimicrobial resistance trends of the P. aeruginosa strains improved after the intervention measures. Multidrug-resistant (MDR) and extensively drug-resistant (XDR) P. aeruginosa contributed to 18.5% and 3.5% of the total P. aeruginosa strains, respectively. Colistin was the most effective antibiotic against 97.6% of XDR-P. aeruginosa and 99.41% of MDR-P. aeruginosa. The consumption of alcohol-based hand gel (ABHG) increased from 0.6 L to 10.8 L per 1,000 patient-days (PD) (p = 0.005). The yearly consumption of antibiotics decreased from 45 to 37.5 defined daily doses (DDD) per 1,000 PD(p = 0.04). After 2013, the incidence rate of MDR-P. aeruginosa showed a significant decrease from 22% to 14.1% (p = 0.04), and XDR-P. aeruginosa decreased from 5.8% to 0.9%. The use of ABHG was negatively related to MDR-P. aeruginosa morbidity (r = -0.86; p = 0.021). The consumption of antibiotics was positively related to MDR-P. aeruginosa morbidity (r = 0.86; p = 0.021). What is new and Conclusion Successful control of MDR-P. aeruginosa resistance was achieved by imposing comprehensive ICPs and AMS.
机构:
Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Microbiol, 1-1-1, Tsushima Naka, Kita ku, Okayama 7008530, JapanOkayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Microbiol, 1-1-1, Tsushima Naka, Kita ku, Okayama 7008530, Japan
Yasuda, Nami
Fujita, Tomoko
论文数: 0引用数: 0
h-index: 0
机构:
Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Microbiol, 1-1-1, Tsushima Naka, Kita ku, Okayama 7008530, JapanOkayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Microbiol, 1-1-1, Tsushima Naka, Kita ku, Okayama 7008530, Japan
Fujita, Tomoko
Fujioka, Takahiro
论文数: 0引用数: 0
h-index: 0
机构:
Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Microbiol, 1-1-1, Tsushima Naka, Kita ku, Okayama 7008530, JapanOkayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Microbiol, 1-1-1, Tsushima Naka, Kita ku, Okayama 7008530, Japan
Fujioka, Takahiro
Tagawa, Mei
论文数: 0引用数: 0
h-index: 0
机构:
Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Microbiol, 1-1-1, Tsushima Naka, Kita ku, Okayama 7008530, JapanOkayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Microbiol, 1-1-1, Tsushima Naka, Kita ku, Okayama 7008530, Japan
Tagawa, Mei
Kohira, Naoki
论文数: 0引用数: 0
h-index: 0
机构:
Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Microbiol, 1-1-1, Tsushima Naka, Kita ku, Okayama 7008530, JapanOkayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Microbiol, 1-1-1, Tsushima Naka, Kita ku, Okayama 7008530, Japan
Kohira, Naoki
Torimaru, Kensho
论文数: 0引用数: 0
h-index: 0
机构:
Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Microbiol, 1-2-3, Kasumi, Minami ku, Hiroshima 7348553, JapanOkayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Microbiol, 1-1-1, Tsushima Naka, Kita ku, Okayama 7008530, Japan
Torimaru, Kensho
Shiota, Sumiko
论文数: 0引用数: 0
h-index: 0
机构:
Shujitsu Univ, Sch Pharm, Dept Mol Biol, 1-6-1 Nishigawara, Naka ku, Okayama 7038516, JapanOkayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Microbiol, 1-1-1, Tsushima Naka, Kita ku, Okayama 7008530, Japan
Shiota, Sumiko
Kumagai, Takanori
论文数: 0引用数: 0
h-index: 0
机构:
Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Microbiol, 1-2-3, Kasumi, Minami ku, Hiroshima 7348553, JapanOkayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Microbiol, 1-1-1, Tsushima Naka, Kita ku, Okayama 7008530, Japan
Kumagai, Takanori
论文数: 引用数:
h-index:
机构:
Morita, Daichi
论文数: 引用数:
h-index:
机构:
Ogawa, Wakano
Tsuchiya, Tomofusa
论文数: 0引用数: 0
h-index: 0
机构:
Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Microbiol, 1-1-1, Tsushima Naka, Kita ku, Okayama 7008530, JapanOkayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Microbiol, 1-1-1, Tsushima Naka, Kita ku, Okayama 7008530, Japan
机构:
Beijing Univ Chinese Med, Dongzhimen Hosp, Dept Emergency Med, Beijing 100700, Peoples R ChinaBeijing Univ Chinese Med, Dongzhimen Hosp, Dept Emergency Med, Beijing 100700, Peoples R China
Kong Ling-bo
Ma Qun
论文数: 0引用数: 0
h-index: 0
机构:
Beijing Univ Chinese Med, Sch Chinese Materia Medica, Beijing 100029, Peoples R ChinaBeijing Univ Chinese Med, Dongzhimen Hosp, Dept Emergency Med, Beijing 100700, Peoples R China
Ma Qun
Gao Jie
论文数: 0引用数: 0
h-index: 0
机构:
Beijing Univ Chinese Med, Dongzhimen Hosp, Dept Emergency Med, Beijing 100700, Peoples R ChinaBeijing Univ Chinese Med, Dongzhimen Hosp, Dept Emergency Med, Beijing 100700, Peoples R China
Gao Jie
Qiu Guo-song
论文数: 0引用数: 0
h-index: 0
机构:
PepMetr Technol Inc, Vancouver, BC, CanadaBeijing Univ Chinese Med, Dongzhimen Hosp, Dept Emergency Med, Beijing 100700, Peoples R China
Qiu Guo-song
Wang Li-xia
论文数: 0引用数: 0
h-index: 0
机构:
PepMetr Technol Inc, Vancouver, BC, CanadaBeijing Univ Chinese Med, Dongzhimen Hosp, Dept Emergency Med, Beijing 100700, Peoples R China
Wang Li-xia
Zhao Shu-min
论文数: 0引用数: 0
h-index: 0
机构:
Beijing Genovax Biotech Corp, Beijing 100089, Peoples R ChinaBeijing Univ Chinese Med, Dongzhimen Hosp, Dept Emergency Med, Beijing 100700, Peoples R China
Zhao Shu-min
Bao Yong-gang
论文数: 0引用数: 0
h-index: 0
机构:
Beijing Genovax Biotech Corp, Beijing 100089, Peoples R ChinaBeijing Univ Chinese Med, Dongzhimen Hosp, Dept Emergency Med, Beijing 100700, Peoples R China
Bao Yong-gang
Liu Qing-quan
论文数: 0引用数: 0
h-index: 0
机构:
Beijing Univ Chinese Med, Dongzhimen Hosp, Dept Emergency Med, Beijing 100700, Peoples R ChinaBeijing Univ Chinese Med, Dongzhimen Hosp, Dept Emergency Med, Beijing 100700, Peoples R China
机构:
Brain Korea 21 PLUS Project Med Sci, Dept Microbiol & Immunol, Seoul, South Korea
Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul 03722, South KoreaBrain Korea 21 PLUS Project Med Sci, Dept Microbiol & Immunol, Seoul, South Korea